Insulin Pump Compatibility: What Devices Work Best with Your Pump?

by

Table of Contents

Understanding Insulin Pump Compatibility: A Comprehensive Guide

Choosing the right devices to work with your insulin pump is one of the most important decisions you’ll make in managing your diabetes. The landscape of diabetes technology has evolved dramatically, with automated insulin delivery (AID) now the recommended standard of care for people with type 1 diabetes and for those with type 2 diabetes on multiple daily injections. Understanding which devices are compatible with your insulin pump can significantly improve your diabetes management, reduce the mental burden of constant calculations, and help you achieve better glycemic outcomes.

Device compatibility isn’t just about technical specifications—it’s about creating an integrated ecosystem that works seamlessly to monitor your glucose levels, deliver insulin automatically, and provide you with actionable data. Whether you’re considering your first insulin pump or looking to upgrade your current system, this comprehensive guide will help you navigate the complex world of insulin pump compatibility.

The Evolution of Insulin Pump Technology

The insulin pump industry has undergone remarkable transformation over the past few decades. The earliest commercial insulin pumps were large devices infusing insulin via metal needles with a comparatively short battery life, little flexibility in the rate of insulin delivery and limited safety alarms, leading to complications of hyperglycaemia and diabetic ketoacidosis. Today’s pumps are sophisticated medical devices that integrate with continuous glucose monitors, smartphone apps, and cloud-based data management platforms.

The 1990s and 2000s saw a revolution in the development of insulin pumps, with safety features such as alerts for infusion set occlusion and low battery or low insulin reservoir integrated alongside the miniaturization of pump devices, longer-life batteries and plastic catheter infusion sets. This evolution has continued into 2026, with manufacturers now focusing on smartphone control, extended wear times, and increasingly sophisticated algorithms that can predict and prevent both high and low glucose events.

Smartphone Compatibility and Mobile App Integration

One of the most significant advances in insulin pump technology has been the integration with smartphones. Modern insulin pumps increasingly rely on dedicated mobile applications that transform your phone into a powerful diabetes management tool. These apps allow you to monitor insulin delivery, adjust settings, view real-time glucose data, and receive critical alerts—all from a device you already carry with you everywhere.

Latest Smartphone-Controlled Pump Systems

MiniMed announced FDA clearance of MiniMed Flex™, a next-generation discreet, smartphone-controlled insulin pump designed to fit seamlessly into everyday life, about half the size of the MiniMed™ 780G pump and roughly the size of two stacked insulin vials. This represents a major shift in pump design philosophy, with the device managed through a compatible mobile app, eliminating the traditional pump screen, with seamless software updates delivered through iOS and Android devices at launch.

The Tandem Mobi system offers similar smartphone integration. Mobi users can view pump/CGM data and deliver boluses from an app on compatible phones, providing a streamlined experience for users who prefer managing their diabetes through their smartphone. The Tandem Mobi Mobile App is available for iOS users in the US, with recent FDA-approval for Android version, with rollout in 2026 in the US.

Operating System Compatibility Considerations

When considering smartphone compatibility, it’s essential to verify that your specific device and operating system version are supported. Turning off Automatic Updates on your mobile device may help you avoid unintentionally updating to an operating system that is not confirmed as compatible, as the MiniMed™ 780G system is a medical device requiring extensive testing on all updates, and you may experience a delay from when Apple or Android™ releases a new operating system and when the mobile apps are compatible.

Most manufacturers maintain updated compatibility lists on their websites, showing which specific phone models and OS versions work with their apps. Before purchasing a new phone or updating your operating system, always check your pump manufacturer’s current compatibility list to avoid disruptions in your diabetes management.

Benefits of Smartphone Integration

Smartphone-controlled pumps offer several advantages over traditional pump controllers:

  • Discreet management: You can check glucose levels and deliver insulin doses without pulling out a separate medical device, making diabetes management more private in social situations
  • Familiar interface: Most people are already comfortable navigating smartphone apps, reducing the learning curve
  • Automatic updates: Software improvements and new features can be delivered wirelessly without requiring new hardware
  • Data sharing: Easy integration with data management platforms and the ability to share information with healthcare providers and caregivers
  • Consolidated devices: Fewer devices to carry and charge throughout the day

Continuous Glucose Monitor (CGM) Integration

The integration between insulin pumps and continuous glucose monitors represents one of the most significant advances in diabetes care. Utilization of technological devices for diabetes management, such as continuous glucose monitors (CGM) and insulin pumps, is increasing, and these devices are associated with improvements in glycemic trends. When properly integrated, these systems can automatically adjust insulin delivery based on real-time glucose readings, creating what’s known as an automated insulin delivery (AID) or hybrid closed-loop system.

How CGM and Pump Integration Works

An automated insulin delivery (AID) system is a technology that connects a continuous glucose monitor (CGM) with an insulin pump, using algorithms to automatically adjust insulin delivery based on real-time glucose readings, predicted glucose trends, and user-defined parameters. This integration happens through wireless communication protocols, typically Bluetooth, that allow the CGM sensor to transmit glucose data to the pump every few minutes.

The insulin pumps and CGM work together by using Dexcom CGM data to predict changes in glucose levels and telling the pump to deliver the appropriate dose of insulin. This predictive capability is crucial—rather than simply reacting to current glucose levels, modern systems can anticipate where your glucose is heading and make proactive adjustments to keep you in range.

Major CGM Systems and Their Pump Compatibility

Dexcom G6 and G7 Integration

Dexcom CGM systems are among the most widely compatible with insulin pumps. The t:slim X2 is compatible with Dexcom G6, Dexcom G7, and FreeStyle Libre 3 Plus in the U.S., offering users the widest CGM options among any Tandem pump. The Dexcom G7 represents the latest generation, offering a smaller sensor profile and faster warm-up time compared to the G6.

Omnipod® 5 is the only waterproof and tubeless Automated Insulin Delivery (AID) system that integrates with Dexcom Continuous Glucose Monitoring (CGM), automatically regulating insulin delivery to help prevent both high and low glucose levels. Omnipod 5 currently supports Dexcom G6, Dexcom G7, and FreeStyle Libre 2 Plus, giving users flexibility in choosing their preferred CGM system.

FreeStyle Libre Integration

Abbott’s FreeStyle Libre systems have expanded their integration capabilities significantly. When connected to a CGM sensor like the FreeStyle Libre 3 Plus sensor or FreeStyle Libre 2 Plus sensor, compatible AID systems are designed to precisely adjust your insulin as your glucose goes up and down. The FreeStyle Libre 3 Plus offers particularly impressive specifications, with the sensor connecting via Bluetooth to the Tandem t:slim X2 insulin pump, with glucose data visualized on the t:connect mobile app and t:slim X2 insulin pump every minute.

The t:slim X2 insulin pump is powered by Control-IQ+ technology, which uses FreeStyle Libre 3 Plus sensor values to predict glucose levels 30 minutes ahead and automatically adjust insulin as needed, with only Tandem pumps having AutoBolus, which helps with missed meal boluses and preventing hyperglycemia. This predictive capability can be particularly valuable for preventing post-meal glucose spikes.

Medtronic Guardian and Simplera Sensors

Medtronic has developed its own CGM sensors that integrate seamlessly with their pump systems. MiniMed 780G uses Medtronic’s Guardian 4 Sensor (with future expansion to Abbott FreeStyle Libre tech) and SmartGuard™ algorithm, including advanced features like Meal Detection and frequent adjustments based on CGM readings. The newer MiniMed Flex system expands compatibility further, with the device supporting the company’s newest sensor portfolio, including Simplera Sync™ sensor and the Instinct sensor, made by Abbott.

Eversense Long-Term CGM

For users seeking longer wear times, the Eversense 365 offers a unique option. Eversense is the only one year CGM cleared for use in automated insulin delivery (AID) systems, starting with the twiist™ AID system. This implantable sensor eliminates the need for frequent sensor changes, though it requires a minor insertion procedure performed by a healthcare provider.

Clinical Benefits of Integrated Systems

The clinical evidence supporting CGM-pump integration is compelling. The approval trial of the 780G system demonstrated a 75.1% average TIR for adults and 72.7% average TIR for adolescents, with adults spending 95.2% time in HCL mode and adolescents spending 93.8% time in HCL mode over 3 months of system use. These time-in-range percentages significantly exceed what most people can achieve with manual insulin dosing.

For the Omnipod 5 system, average day time in Target Glucose range in adults/adolescents and children for standard therapy vs Omnipod 5 was 64.8% vs. 72.5% and 51.5% vs. 64.6%, while average overnight in Target Glucose range was 64.3% vs. 78.1% and 55.3% vs. 78.1%. The overnight improvements are particularly significant, as they allow for better sleep quality and reduced anxiety about nighttime hypoglycemia.

Current Insulin Pump Systems and Their Compatibility Profiles

Understanding the specific compatibility features of each major insulin pump system can help you make an informed decision about which device best meets your needs. Here’s a comprehensive overview of the leading systems available in 2026.

Tandem Diabetes Care Systems

Tandem t:slim X2

The t:slim X2 features a bright touchscreen display and uses the Control-IQ+ algorithm, with its larger 300-unit reservoir ideal for individuals with higher insulin needs. This pump offers the broadest CGM compatibility in the Tandem lineup, working with Dexcom G6, Dexcom G7, and FreeStyle Libre 3 Plus sensors. The touchscreen interface provides an intuitive user experience similar to a smartphone, making it easier for new pump users to learn the system.

The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. This interoperability is crucial for future-proofing your diabetes management system, as it allows the pump to work with new algorithms and software updates as they become available.

Tandem Mobi

The Tandem Mobi represents a shift toward smaller, more discreet pump designs. The Mobi is best for people who want the smallest durable AID pump, prefer smartphone control, and are comfortable with a tubed system, though it needs a compatible iPhone or Android device for full control. CGM compatibility is limited to Dexcom G6 and standard Dexcom G7 — does not currently work with FreeStyle Libre sensors, which is an important consideration if you prefer Abbott’s CGM technology.

Not only can users wear Mobi in an adhesive patch with 5″ tubing, Tandem has announced that they are working on a patch version of Mobi, which would eliminate tubing entirely and compete directly with tubeless systems like Omnipod 5.

Insulet Omnipod 5

Omnipod 5 is a tubeless patch pump with pods that typically last approximately 3 days per pod (72 hours) before replacement and hold up to 200 units of insulin, with CGM integrations including Dexcom G6 and Dexcom G7 sensors, bringing hybrid closed-loop automation without tubes with SmartAdjust™ technology updating insulin delivery every approximately 5 minutes based on CGM data.

One significant advantage of the Omnipod 5 is its flexibility in control options. Omnipod 5 can be controlled with the compatible smartphone app or the Omnipod PDM controller — a smartphone is not necessary. This makes it accessible to users who prefer not to use their phone for diabetes management or who want a backup control option.

Omnipod 5 is also FDA-approved for adults with type 2 diabetes who use insulin, expanding access to automated insulin delivery beyond the type 1 diabetes community. The waterproof design makes it particularly appealing for swimmers and athletes who want to maintain active lifestyles without worrying about disconnecting their pump.

Medtronic MiniMed Systems

MiniMed 780G

The MiniMed 780G has been a workhorse in the automated insulin delivery space. The advanced hybrid closed-loop 780G system includes automated basal insulin delivery based upon total daily insulin requirements over previous days as well as automatic correction dose delivery. This system learns from your insulin needs over time, continuously refining its delivery patterns to match your body’s requirements.

The 780G also supports an extended infusion set worn up to approximately 7 days, meaning fewer site changes. This extended wear capability can significantly reduce the burden of diabetes management, as infusion set changes are one of the more time-consuming and sometimes uncomfortable aspects of pump therapy.

MiniMed Flex

The newest addition to Medtronic’s lineup represents a significant departure from traditional pump design. MiniMed Flex features a small, sleek design with high insulin capacity, designed to be worn wherever users prefer — in a pocket or out of sight — while delivering a 300-unit insulin reservoir to support a range of insulin needs, and is managed through a compatible mobile app, eliminating the traditional pump screen, with seamless software updates delivered through iOS and Android devices at launch.

MiniMed Flex™ is powered by the company’s most advanced SmartGuard™ algorithm with Meal Detection™ technology, which has proven clinical performance that exceeds worldwide Time in Range recommendations. The Meal Detection feature is particularly innovative, as it can recognize when you’re eating based on glucose patterns and automatically deliver additional insulin without requiring you to announce meals.

Beta Bionics iLet Bionic Pancreas

iLet is a closed-loop AID system with up to 200 units of insulin capacity and CGM integrations including Dexcom G6, Dexcom G7, and Abbott FreeStyle Libre 3 Plus, designed to be even more “hands-off” than traditional AID systems — it adapts insulin delivery based on body weight and CGM data without requiring preset basal rates or complex settings, with some versions emphasizing minimal manual correction and learning insulin patterns automatically.

This innovative insulin pump automatically adjusts insulin based on the Dexcom CGM readings, so users don’t have to worry about making constant decisions, and users can forget about carb counting, needing only to estimate the carbs in their meal by choosing from three options: usual for me, more, or less, as the iLet continuously learns about the user and their routine over time. This simplified approach can be particularly appealing for people who find traditional carb counting burdensome or who want a more intuitive system.

twiist AID System

twiist is an emerging hybrid closed-loop pump system with 300 units insulin capacity, designed for use with popular CGMs (Dexcom, others; see approvals per region and clinician guidance), powered by interoperable algorithms that aim to offer personalized automated insulin delivery using real-time CGM data, with compatibility and specific features varying by region and approval status.

The twiist AID System powered by Tidepool and the FreeStyle Libre 3 Plus sensor create one easy, integrated experience, with automatic readings sent straight from the sensor to the twiist pump every minute. The system also includes the twiist insiight app allowing parents and caregivers to see the glucose and insulin data of their loved ones, which is particularly valuable for parents of children with diabetes.

Data Management and Cloud Connectivity

Beyond the pump and CGM themselves, compatibility with data management platforms is crucial for comprehensive diabetes care. These platforms allow you to review trends, share data with healthcare providers, and gain insights that can improve your management strategies.

Major Data Management Platforms

Glooko: Glooko puts all of your glucose readings, insulin data and fitness tracking stats together in one app, allowing you to stay on track with personalized tips, simple reports, and share with your healthcare team. Glooko is compatible with most major pump and CGM systems, making it a versatile choice if you use devices from different manufacturers.

Tidepool: Tidepool is a nonprofit organization providing software that makes diabetes data – pump, meter, CGM – more accessible, meaningful, and actionable within the Tidepool Data Platform. As a nonprofit, Tidepool’s mission is focused on improving diabetes care rather than profit, and they offer their platform free of charge to people with diabetes.

Apple Health Integration: Many CGM systems now offer integration with Apple Health. Within the Eversense 365 App, the Share My Data feature allows you to share your Eversense data with Apple Health by tapping the Apple Health application and turning on Share Data, though you may need to also allow sharing via the health application. This integration allows your diabetes data to be part of your broader health picture, alongside activity, sleep, and other health metrics.

Remote Monitoring and Caregiver Access

For parents of children with diabetes, caregivers, and people who want to share their data with loved ones, remote monitoring capabilities are essential. You will be able to display key insulin pump data right on your smart device, discovering a new way to interact with your MiniMed insulin pump and continuous glucose monitoring (CGM) data, with an easy way for care partners to remotely view the glucose levels and insulin pump information of a person with diabetes.

You can share your glucose data with family, friends, and caregivers using the LibreLinkUp app, with caregivers able to set and receive glucose alarms and notifications in the LibreLinkUp app. This feature provides peace of mind for caregivers while allowing the person with diabetes to maintain independence.

Smartwatch and Wearable Device Compatibility

Smartwatches have become increasingly popular as secondary displays for diabetes data. You can view a snapshot of your CGM data on your Apple Watch, though the wearable is a secondary display of Eversense data and should not be used in place of the primary CGM app display. This allows for quick glucose checks without pulling out your phone, which can be particularly convenient during meetings, workouts, or while driving.

Most major CGM systems now offer Apple Watch compatibility, with some also supporting Android-based smartwatches. The watch displays typically show your current glucose reading, trend arrow, and time since last reading. Some apps also allow you to view graphs of recent glucose trends directly on your wrist.

It’s important to note that smartwatch displays are meant for convenience and quick reference, not for making treatment decisions. Always refer to your primary CGM app or receiver when deciding on insulin doses or treating high or low glucose levels.

Open-Source AID Systems and DIY Solutions

For technically inclined users seeking more customization and control, open-source automated insulin delivery systems offer an alternative to commercial options. Open-source AID systems like Loop, AndroidAPS, and Trio combine pumps, CGMs, and smartphone apps to deliver customizable insulin automation, with unique features, safety considerations, and clinicians able to support patients using these evolving tools.

To use AAPS you need three compatible devices: (1) an Android phone, (2) a continuous glucose monitor (CGM), and (3) a FDA/CE approved insulin pump, with optional cloud services to remote control AAPS, share your data and store them in a reporting server, and a smartwatch. Android APS (AAPS) is an open source app for people living with insulin-dependent diabetes, an artificial pancreas system (APS) which runs on Android smartphones, using an OpenAPS software algorithm and aiming to do what a real pancreas does: keep blood sugar levels within healthy limits by using automated insulin dosing.

However, it’s crucial to understand the safety considerations. The safety of AAPS relies on the safety features of your hardware (phone, pump, CGM), and you should only use a fully functioning FDA/CE approved insulin pump and CGM, not broken, modified or self-built insulin pumps or CGM receivers, and only use original consumable supplies approved by the manufacturer for use with your pump and CGM, as using untested or modified supplies can cause inaccuracy and insulin dosing errors, resulting in significant risk to the user.

Open-source systems require technical knowledge to set up and maintain, and users take on responsibility for their own safety. While these systems have passionate user communities and can offer features not available in commercial systems, they’re not appropriate for everyone. Discuss with your healthcare provider whether an open-source system might be right for you.

Infusion Sets and Extended Wear Options

While often overlooked in discussions of compatibility, infusion sets are a critical component of insulin pump therapy. The infusion set is what actually delivers insulin from your pump into your body, and compatibility varies by pump manufacturer.

MiniMed Flex works with MiniMed’s infusion set portfolio, including the Extended™ infusion set with up to 7 days of wear, delivering up to 96% fewer injections compared with traditional insulin therapy. Extended wear infusion sets represent a significant advancement, as traditional sets typically require changing every 2-3 days. Tandem reported FDA clearance in late 2025 for extended-wear use of the SteadiSet infusion set, with a wider commercial rollout expected afterward — potentially halving site change frequency.

When choosing a pump system, consider the infusion set options available. Some people have sensitivities to certain adhesives or prefer specific insertion angles (90-degree vs. angled sets). Most pump manufacturers offer several infusion set options, but it’s worth confirming that sets compatible with your skin type and preferences are available for your chosen pump.

Insulin Compatibility Considerations

Not all insulin pumps are approved for use with all types of insulin. Most pumps are approved for rapid-acting insulin analogs, but specific brands may vary. Approved Insulins for some systems include NovoRapid®, NovoLog®, Trurapi®, Kirsty®, Humalog®, Admelog® 100 U/mL, with reports of Humalog® 200 U/mL usage lacking supporting data and constituting off-label use.

Some systems have received approval for ultra-rapid-acting insulins like Fiasp or Lyumjev, which can provide faster insulin action and potentially better post-meal glucose control. European Approval has been granted for Lyumjev®, based on positive trial results for certain pump systems. Always verify that your preferred insulin is approved for use with your pump, and never use insulin types that aren’t specifically approved, as this could affect the accuracy of the pump’s calculations and put you at risk.

Making the Right Compatibility Choices for Your Lifestyle

With so many options available, choosing the right combination of devices can feel overwhelming. Here are key factors to consider when evaluating compatibility:

Your Daily Routine and Activities

Consider how you spend your days. If you’re very active or swim frequently, a waterproof tubeless system like Omnipod 5 might be ideal. If you prefer the smallest possible profile and are comfortable with smartphone control, the Tandem Mobi or MiniMed Flex could be better choices. For those with higher insulin needs, pumps with 300-unit reservoirs like the t:slim X2 or MiniMed Flex offer longer wear times between reservoir changes.

Your Comfort with Technology

Some systems require more user input and adjustment than others. The iLet Bionic Pancreas is designed to be highly automated with minimal user intervention, while systems like the t:slim X2 offer more granular control for users who want to fine-tune their settings. Consider your comfort level with technology and how much control you want over your diabetes management decisions.

CGM Preferences

If you already have a CGM you love, check which pumps are compatible with it. Conversely, if you’re starting fresh, consider which CGM features matter most to you—sensor size, wear time, calibration requirements, and accuracy can all vary. Some people prefer the no-calibration convenience of Dexcom systems, while others appreciate the longer wear time of Eversense or the minute-by-minute readings of FreeStyle Libre 3 Plus.

Insurance Coverage and Cost

Insurance coverage can significantly impact which devices are accessible to you. Some insurance plans have preferred pump manufacturers or may cover certain CGM systems but not others. Before making a decision, verify coverage with your insurance provider and understand your out-of-pocket costs for both the initial devices and ongoing supplies.

Healthcare Provider Support

Your healthcare team’s experience with different systems matters. The diabetes care and education specialist who chooses to work with individuals on sensor augmented insulin pumps must be aware of the options, keep up with the technology, understand the benefits and limitations, be able to download the technology and help direct the interpretation of the data. If your endocrinologist and diabetes educator have extensive experience with a particular system, that expertise can be invaluable during your learning curve and when troubleshooting issues.

Setting Up and Optimizing Your Integrated System

Once you’ve chosen compatible devices, proper setup and optimization are crucial for getting the best results. Pump training will often occur over multiple days, with an initial visit for pump training, another visit for CGM training and a subsequent visit to go into auto mode. This staged approach allows you to become comfortable with each component before integrating them into a fully automated system.

Initial Training and Education

Comprehensive training is essential for safe and effective use. Do not use MiniMed™ 780G system until appropriate training has been received from a healthcare professional, as training is essential to ensure the safe use of the system. This principle applies to all insulin pump systems. Your training should cover:

  • Basic pump operation and insulin delivery
  • CGM sensor insertion and calibration (if required)
  • Understanding and responding to alerts and alarms
  • Troubleshooting common issues
  • When to contact your healthcare provider
  • Emergency procedures and backup plans

Ongoing Optimization

The specialist should be able to download data from the integrated insulin pump, review the information with the individual and make recommendations based on sensor data that can enhance glucose goals, should have an ongoing relationship with the prescriber and communicate these changes, with education being ongoing and pump upgrades as they become available reviewed and discussed as appropriate.

Regular data review is crucial for optimizing your system. Most platforms allow you to generate reports showing your time in range, average glucose, glucose variability, and patterns throughout the day. These reports can help you and your healthcare team identify opportunities for improvement, such as adjusting your insulin-to-carb ratios, correction factors, or automated delivery settings.

Troubleshooting Compatibility Issues

Even with compatible devices, you may occasionally encounter connectivity or communication issues. Here are common problems and solutions:

Bluetooth Connectivity Problems

Underpinning the success of current AID systems has been Bluetooth connectivity, with advances in engineering enabling better connectivity, which may lead to improved diabetes devices and user experience. However, Bluetooth can sometimes be finicky. If you’re experiencing connection issues:

  • Ensure Bluetooth is enabled on your phone and pump/CGM
  • Keep devices within the recommended range (typically 20 feet)
  • Restart both devices if connection is lost
  • Check for software updates that may resolve connectivity bugs
  • Minimize interference from other Bluetooth devices
  • Ensure your phone’s operating system is on the compatibility list

Sensor Communication Failures

If your pump isn’t receiving CGM data, first check that the sensor is still active and hasn’t expired. Verify that the sensor transmitter is properly attached and that the sensor hasn’t been accidentally dislodged. Some systems require you to be within a certain distance of the transmitter, so if you’ve left your pump or phone in another room, that could explain the loss of signal.

App Crashes or Freezes

Smartphone apps can occasionally crash or freeze. Always keep your pump app updated to the latest version, as manufacturers regularly release bug fixes. If problems persist, try uninstalling and reinstalling the app, but be aware that this may require re-pairing your devices. Contact your pump manufacturer’s technical support if issues continue.

The Future of Insulin Pump Compatibility

The diabetes technology landscape continues to evolve rapidly. New sensors, smarter algorithms, sleeker form factors — every year the devices get a little better, a little smaller, and a little more integrated into everyday life, with 2026 being no exception, as there’s a lot happening across the diabetes device landscape right now, from longer-wear sensors and new pump designs to AI-driven software that helps make sense of CGM data without the mental load.

Interoperability Standards

With respect to commercial HCL systems, interoperability refers to approved connection between various commercial insulin pumps with CGM devices, not adversarial interoperability, otherwise known as competitive compatibility, which is the communication between systems despite the resistance of one or more of the connecting systems. The push toward true interoperability—where any compatible pump can work with any compatible CGM—would give users unprecedented freedom to mix and match components based on their preferences.

The FDA has established categories for interoperable devices, including iCGM (interoperable CGM) and ACE (alternate controller enabled) pumps. These designations are designed to facilitate the development of integrated systems while maintaining safety standards. As more devices receive these designations, we can expect greater flexibility in creating customized diabetes management systems.

Artificial Intelligence and Machine Learning

Future systems will likely incorporate more sophisticated AI and machine learning algorithms that can learn from your patterns and make increasingly accurate predictions. Advances may enable opportunities to consider connectivity between different combinations of devices and integrate data from different sources for improved outcomes, with future work potentially overcoming the challenges in connectivity and interoperability and defining standards for AI and information exchange between diabetes devices.

These advanced algorithms could potentially account for factors beyond glucose and insulin, such as activity levels from fitness trackers, sleep quality from smartwatches, meal composition from food logging apps, and even stress levels from biometric sensors. This holistic approach could lead to even better glucose control with less user input required.

Dual-Hormone Systems

Future developments may include dual hormone systems (glucagon and insulin) with sensor integration, implantable sensors and pumps and fully integrated sensor and pump systems (the artificial pancreas). Dual-hormone systems that deliver both insulin and glucagon could provide even tighter glucose control by not only lowering high glucose levels but also actively preventing and treating lows.

Essential Compatibility Checklist

Before committing to a new insulin pump system, use this comprehensive checklist to ensure all your compatibility needs are met:

Device Compatibility

  • Verify your preferred CGM is compatible with the pump
  • Check that your smartphone model and OS version are supported
  • Confirm your insulin type is approved for the pump
  • Ensure infusion set options meet your needs (insertion angle, tubing length, adhesive type)
  • Verify smartwatch compatibility if you plan to use one

Software and Data Management

  • Confirm compatibility with your preferred data management platform (Glooko, Tidepool, etc.)
  • Check if the system supports remote monitoring for caregivers if needed
  • Verify that data can be easily shared with your healthcare provider
  • Ensure the system integrates with any other health apps you use

Practical Considerations

  • Confirm insurance coverage for all components
  • Verify your healthcare team has experience with the system
  • Check availability of supplies in your area
  • Understand warranty terms and upgrade policies
  • Review customer support options and hours

Safety and Backup Plans

  • Understand what happens if connectivity is lost
  • Have a backup plan for pump failures
  • Know how to manually deliver insulin if needed
  • Keep backup supplies of insulin pens or syringes
  • Understand how to interpret and respond to all alerts and alarms

Maximizing the Benefits of Your Integrated System

Relying on an integrated system lessens some of the burden and frees you to focus on being present throughout your day, and a closed-loop system may also help you reach your time in range (TIR) and A1C goals. To get the most from your compatible devices:

Stay Current with Updates: Manufacturers regularly release software updates that improve performance, add features, and fix bugs. Enable automatic updates when possible, or check regularly for new versions.

Review Your Data Regularly: With a CGM-compatible insulin pump, you can pass on some of the mental math that goes into administering insulin levels to your diabetes devices, and finding the right tools to aid your glucose management can help you feel better and enjoy the things you love to do, with a Dexcom CGM-compatible insulin pump helping you get even more from your CGM by automating glucose monitoring and insulin delivery.

Customize Settings to Your Lifestyle: Some pumps let you set up different insulin delivery schedules that work with your lifestyle, for example setting up weekday and weekend schedules to accommodate changes in your sleeping and eating habits, and you can also set the pump to align insulin delivery with changes in your physical activity levels and sleep schedule.

Engage with the Community: Online communities of pump users can be invaluable resources for tips, troubleshooting advice, and emotional support. Many manufacturers also host user forums where you can connect with other people using the same system.

Maintain Open Communication with Your Healthcare Team: Regular check-ins with your endocrinologist and diabetes educator ensure your system is optimized for your current needs. As your life circumstances change—new job, different activity level, pregnancy, aging—your insulin needs and optimal settings may change too.

Conclusion: Empowering Your Diabetes Management Through Compatible Technology

The integration of insulin pumps with continuous glucose monitors, smartphones, and data management platforms represents one of the most significant advances in diabetes care. Establishing connectivity between insulin pumps and CGM devices has enabled significant improvements in diabetes care, with the emergence of AID systems, particularly HCLs, having a significant and positive impact on the lives of people living with T1D, and the evidence highlighting the potential benefits that these devices can deliver at a population level.

Understanding compatibility—between pumps and CGMs, smartphones and apps, data platforms and healthcare providers—is essential for creating a diabetes management system that works seamlessly in your life. The right combination of compatible devices can reduce the daily burden of diabetes management, improve your glucose control, and give you more freedom to focus on living your life rather than constantly managing your condition.

As technology continues to advance, the options will only expand. 2026 isn’t about one blockbuster announcement but about the diabetes device ecosystem getting smarter, more flexible, and more personal — from how pumps are worn to how sensors interpret metabolic data to how algorithms adapt to individual needs. By staying informed about compatibility options and working closely with your healthcare team, you can make choices that optimize your diabetes management both now and in the future.

Remember that the “best” system is the one that works best for you—considering your lifestyle, preferences, insurance coverage, and healthcare support. Take time to research your options, ask questions, and don’t hesitate to request trial periods or demonstrations when possible. Your diabetes management system should support your life, not complicate it, and with the right compatible devices, that goal is more achievable than ever before.

For more information about specific insulin pump systems and their compatibility features, visit the manufacturer websites or consult with your endocrinologist and certified diabetes educator. They can provide personalized guidance based on your individual needs and help you navigate the process of selecting and setting up your integrated diabetes management system.

Additional Resources